VEnvirotech | From waste to value: Transforming organic waste into biodegradable bioplastics

Summary
Every year 8M tonnes of plastics trash enter the sea. Plastic materials that leak into the environment are a global pollution problem as they may take up to 2.000 years to degrade. The European Parliament agreed on measures to eliminate single-use plastics by 2030 as part of the EU Plastics Strategy. We have to be aware about the need to shift our industry and the use of biodegradable bioplastics. A potential solution are PHA bioplastics, biodegradable and produced by bacteria. Unfortunately, because of their costly production process, currently marketed PHA (5-20€/kg) cannot compete with conventional plastics (1-2€/kg)
VEnvirotech Biotechnology is a biotechnology start-up founded in April 2018 aiming to offer a solution to the plastic problem by transform organic waste into biodegradable PHA bioplastics while using bacteria. Our innovation relies on the application of biotechnology to organic waste treatment processes at industrial scale to obtain a revalorized product in the form of bioplastic. We have developed two processes: a waste treatment process that uses bacteria to digest organic waste from industrial companies. By inducing feeding and famine cycles to bacteria with the grinded and fermented organic waste, bacteria accumulate PHA bioplastic as energy reserve. This selective pressure process is repeated in our VE-Box a portable processing plant capable of producing high quality PHA biodegradable bioplastics as added-value from organic waste. The bacteria with PHA is taken from the VE-Box to VEnvirotech’s centralized plants to extract, purify and formulate our VE-0plastic.
We can reduce by 30% the costs of waste management and by 50% the price of bioplastic. The opportunity in the global waste management market and bioplastics market represents a combined TAM of €447B by 2024. We have defined a commercialization strategy to start in Spain by 2022 and expand to Europe in the following years. By 2024 we expect to have €75M in revenues and a net profit of €11M
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/888704
Start date: 01-11-2019
End date: 29-02-2020
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

Every year 8M tonnes of plastics trash enter the sea. Plastic materials that leak into the environment are a global pollution problem as they may take up to 2.000 years to degrade. The European Parliament agreed on measures to eliminate single-use plastics by 2030 as part of the EU Plastics Strategy. We have to be aware about the need to shift our industry and the use of biodegradable bioplastics. A potential solution are PHA bioplastics, biodegradable and produced by bacteria. Unfortunately, because of their costly production process, currently marketed PHA (5-20€/kg) cannot compete with conventional plastics (1-2€/kg)
VEnvirotech Biotechnology is a biotechnology start-up founded in April 2018 aiming to offer a solution to the plastic problem by transform organic waste into biodegradable PHA bioplastics while using bacteria. Our innovation relies on the application of biotechnology to organic waste treatment processes at industrial scale to obtain a revalorized product in the form of bioplastic. We have developed two processes: a waste treatment process that uses bacteria to digest organic waste from industrial companies. By inducing feeding and famine cycles to bacteria with the grinded and fermented organic waste, bacteria accumulate PHA bioplastic as energy reserve. This selective pressure process is repeated in our VE-Box a portable processing plant capable of producing high quality PHA biodegradable bioplastics as added-value from organic waste. The bacteria with PHA is taken from the VE-Box to VEnvirotech’s centralized plants to extract, purify and formulate our VE-0plastic.
We can reduce by 30% the costs of waste management and by 50% the price of bioplastic. The opportunity in the global waste management market and bioplastics market represents a combined TAM of €447B by 2024. We have defined a commercialization strategy to start in Spain by 2022 and expand to Europe in the following years. By 2024 we expect to have €75M in revenues and a net profit of €11M

Status

CLOSED

Call topic

EIC-SMEInst-2018-2020

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.0. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.0. INDUSTRIAL LEADERSHIP - Innovation In SMEs - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.0. Cross-cutting call topics
H2020-EIC-SMEInst-2018-2020
H2020-SMEInst-2018-2020-1